Skip to main content
. 2019 Aug 16;35(5):697–708. doi: 10.1002/joa3.12226

Table 1.

Baseline characteristics of the patients

  Overall
(n = 2113)
Warfarin
(n = 725)
DOAC
(n = 1118)
P value
Male (%) 1459 (69%) 493 (68%) 778 (70%) .471
Weight (kg) 63.9 ± 12.7 62.5 ± 12.6 65.0 ± 12.7 <.001
Age (years old) 70.1 ± 10.8 73.1 ± 9.9 68.9 ± 10.5 <.001
20‐29 8 (0.4%) 0 (0%) 5 (0.4%)  
30‐39 17 (0.8%) 2 (0.3%) 9 (0.8%)  
40‐49 72 (3.4%) 14 (2%) 39 (3%)  
50‐59 225 (11%) 52 (7%) 129 (12%)  
60‐69 616 (29%) 165 (23%) 364 (33%)  
70‐79 782 (37%) 289 (40%) 419 (37%)  
80‐89 366 (17%) 191 (26%) 143 (13%)  
90‐99 27 (1.3%) 12 (2%) 10 (1%)  
≥75 761 (36%) 266 (37%) 379 (34%) <.001
Range 20‐95 37‐94 20‐94  
Serum creatinine (mg/dL) 0.97 ± 0.65 1.07 ± 0.75 0.88 ± 0.36 <.001
Type of AF       <.001
Paroxysmal AF 1,066 (50%) 273 (38%) 595 (53%)  
Persistent AF 546 (26%) 180 (25%) 319 (29%)  
Long lasting persistent AF 501 (24%) 272 (37%) 204 (18%)  
Symptomatic 1,136 (54%) 351 (48%) 624 (56%) .002
Palpitation 916 (43%) 255 (35%) 522 (47%) <.001
Shortness of breath 341 (16%) 163 (22%) 160 (14%) <.001
General fatigue 102 (5%) 50 (7%) 47 (4%) .014
Dizziness 40 (2%) 14 (2%) 18 (2%) .590

Values are presented as the mean ± SD or n (%).

Abbreviations: AF, atrial fibrillation; DOAC, direct oral anticoagulant.